IP Library › Assignment 040878/0943
Patent Assignment
Reel/Frame 040878/0943

Change of Address of the Assignee

Recorded: 2016-11-02 Pages: 3
Assignor
ONYX THERAPEUTICS, INC.
Executed: 2016-10-25
Assignee
ONYX THERAPEUTICS, INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320
Covered Properties (8)
Compounds for Enzyme Inhibition
Patent: 7,232,818 →
Application: 11/106,879 →
Publication: US 2005/0245435
Compounds for Enzyme Inhibition
Patent: 7,417,042 →
Application: 11/199,899 →
Publication: US 2006/0030533
Composition for Enzyme Inhibition
Patent: 7,737,112 →
Application: 11/299,265 →
Publication: US 2006/0128611
Compounds for Enzyme Inhibition
Patent: 8,129,346 →
Application: 11/578,626 →
Publication: US 2008/0200398
Compounds for Enzyme Inhibition
Patent: 7,491,704 →
Application: 11/786,217 →
Publication: US 2007/0191284
Compounds for Enzyme Inhibition
Patent: 8,207,125 →
Application: 13/334,288 →
Publication: US 2012/0101048
Compounds for Enzyme Inhibition
Patent: 8,207,126 →
Application: 13/334,466 →
Publication: US 2012/0094929
Compounds for Enzyme Inhibition
Patent: 8,207,127 →
Application: 13/334,544 →
Publication: US 2012/0094926
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Mar 3, 2010
From: PROTEOLIX, INC.
To: ONYX THERAPEUTICS, INC.
Reel/Frame 024018/0157 →
Merger May 14, 2010
From: PROTEOLIX, INC.
To: ONYX THERAPEUTICS, INC.
Reel/Frame 024380/0824 →
Assignment of Assignor's Interest Jan 10, 2012
From: SMYTH, MARK S.; LAIDIG, GUY J.
To: PROTEOLIX, INC.
Reel/Frame 027506/0588 →
Merger Jan 10, 2012
From: PROTEOLIX, INC.
To: ONYX THERAPEUTICS, INC.
Reel/Frame 027507/0396 →